Find out more about Ian Faragher's experience
Ian Faragher's highlights
Ian Faragher's selected work
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Thera..
Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefi..
Treatment of colonoscopic perforation: outcomes from a major single tertiary institution
Serial circulating tumour DNA analysis during multimodality treatment of locally advanced ..
Displaying the 64 most recent scholarly works by Ian Faragher.
State-wide outcomes in elective rectal cancer resection: is there a case for centralization in Victoria?
Michael K-Y Hong, Justin MC Yeung, David AK Watters, Ian G Faragher
Journal article | 2019 | ANZ Journal of Surgery
BACKGROUND: The role of service centralization in rectal cancer surgery is controversial. Recent studies suggest centralization to..
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
Jeanne Tie, Joshua D Cohen, Yuxuan Wang, Michael Christie, Koen Simons, Margaret Lee, Rachel Wong, Suzanne Kosmider, Sumitra Ananda, Joseph McKendrick, Belinda Lee, Jin Hee Cho, Ian Faragher, Ian T Jones, Janine Ptak, Mary J Schaeffer, Natalie Silliman, Lisa Dobbyn, Lu Li, Cristian Tomasetti, et al.
Journal article | 2019 | JAMA Oncology
Importance: Adjuvant chemotherapy in patients with stage III colon cancer prevents recurrence by eradicating minimal residual dise..
Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer.
David S Williams, Dmitri Mouradov, Clare Browne, Michelle Palmieri, Meg J Elliott, Rebecca Nightingale, Catherine G Fang, Rita Li, John M Mariadason, Ian Faragher, Ian T Jones, Leonid Churilov, Niall C Tebbutt, Peter Gibbs, Oliver M Sieber
Journal article | 2019 | Modern Pathology
TP53 mutations drive colorectal cancer development, with missense mutations frequently leading to accumulation of abnormal TP53 pr..
Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study
Jeanne Tie, Joshua D Cohen, Yuxuan Wang, Lu Li, Michael Christie, Koen Simons, Hany Elsaleh, Suzanne Kosmider, Rachel Wong, Desmond Yip, Margaret Lee, Tran Ben, David Rangiah, Matthew Burge, David Goldstein, Madhu Singh, Iain Skinner, Ian Faragher, Matthew Croxford, Carolyn Bampton, et al.
Journal article | 2019 | Gut
Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes
David S Williams, Dmitri Mouradov, Robert N Jorissen, Marsali R Newman, Elham Amini, David K Nickless, Julie A Teague, Catherine G Fang, Michelle Palmieri, Marie J Parsons, Anuratha Sakthianandeswaren, Shan Li, Robyn L Ward, Nicholas J Hawkins, Ian Faragher, Ian T Jones, Peter Gibbs, Oliver M Sieber
Journal article | 2019 | Gut
SCORE: Shared care of Colorectal cancer survivors: protocol for a randomised controlled trial
Michael Jefford, Jon Emery, Eva Grunfeld, Andrew Martin, Paula Rodger, Alexandra M Murray, Richard De Abreu Lourenco, Alexander Heriot, Jo Phipps-Nelson, Lisa Guccione, Dorothy King, Karolina Lisy, Niall Tebbutt, Adele Burgess, Ian Faragher, Rodney Woods, Penelope Schofield
Journal article | 2017 | Trials
Survival Impact of Adjuvant Chemotherapy for Resected Locally Advanced Rectal Adenocarcinoma
Rebecca Y Tay, Murtaza Jamnagerwalla, Malcolm Steel, Hui-Li Wong, Joseph J McKendrick, Ian Faragher, Suzanne Kosmider, Ian Hastie, Jayesh Desai, Mark Tacey, Peter Gibbs, Rachel Wong
Journal article | 2017 | CLINICAL COLORECTAL CANCER
Impact of Surgical Complications Following Resection of Locally Advanced Rectal Adenocarcinoma on Adjuvant Chemotherapy Delivery and Survival Outcomes
Murtaza Jamnagerwalla, Rebecca Tay, Malcolm Steel, Jamie Keck, Ian Jones, Ian Faragher, Peter Gibbs, Rachel Wong
Journal article | 2016 | Diseases of the Colon & Rectum
Improving Quality of Life for People with Incurable Large-Bowel Obstruction: Randomized Control Trial of Colonic Stent Insertion
Christopher J Young, Katie J De-loyde, Jane M Young, Michael J Solomon, Emily H Chew, Chris M Byrne, Glenn Salkeld, Ian G Faragher
Journal article | 2015 | Diseases of the Colon & Rectum
Comparing Oncological Outcomes of Laparoscopic Versus Open Surgery for Colon Cancer: Analysis of a Large Prospective Clinical Database
T Sammour, Ian T Jones, P Gibbs, R Chandra, Malcolm C Steel, Susan M Shedda, M Croxford, I Faragher, Ian P Hayes, Ian A Hastie
Journal article | 2015 | Journal of Surgical Oncology
Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation
Nishi Kothari, Richard Kim, Robert N Jorissen, Jayesh Desai, Jeanne Tie, Hui-Li Wong, Ian Farragher, Ian Jones, Fiona L Day, Shan Li, Anuratha Sakthinandeswaren, Michelle Palmieri, Lara Lipton, Michael Schell, Jamie K Teer, David Shibata, Timothy Yeatman, Oliver M Sieber, Peter Gibbs, Ben Tran
Journal article | 2015 | Acta Oncologica
Survival impact of adjuvant chemotherapy for resected early-stage rectal adenocarcinoma.
Rebecca Yin Tay, Murtaza Jamnagerwalla, Malcolm Steel, Hui-Li Wong, Joseph James McKendrick, Ian Faragher, Suzanne Kosmider, Ian Hastie, Jayesh Desai, Peter Gibbs, Rachel Wong
Conference Proceedings | 2015 | Journal of Clinical Oncology
RCT OF COLONIC STENT INSERTION VS. SURGICAL DECOMPRESSION FOR PATIENTS WITH MALIGNANT INCURABLE LARGE BOWEL OBSTRUCTION
Christopher Young, Katie De-loyde, Jane Young, Michael Solomon, Emily Hwee Chew, Chris Byrne, Ian Faragher
Conference Proceedings | 2013 | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
Dietary antioxidants and risk of Barrett's esophagus and adenocarcinoma of the esophagus in an Australian population.
Torukiri I Ibiebele, Maria Celia Hughes, Christina M Nagle, Christopher J Bain, David C Whiteman, Penelope M Webb, undefined Study of Digestive Health and Australian Cancer Study
Journal article | 2013 | International Journal of Cancer
While dietary antioxidants are emerging as potentially modifiable risk factors for esophageal adenocarcinoma (EAC), studies on die..
Long-term outcomes of the australasian randomized clinical trial comparing laparoscopic and conventional open surgical treatments for colon cancer: the Australasian Laparoscopic Colon Cancer Study trial.
Philip F Bagshaw, Randall A Allardyce, Christopher M Frampton, Francis A Frizelle, Peter J Hewett, Paul J McMurrick, Nicholas A Rieger, J Shona Smith, Michael J Solomon, Andrew RL Stevenson, undefined Australasian Laparoscopic Colon Cancer Study Group
Journal article | 2012 | Annals of Surgery
OBJECTIVE: : We report a multicentered randomized controlled trial across Australia and New Zealand comparing laparoscopic-assiste..
Dietary patterns and risk of oesophageal cancers: a population-based case–control study
Torukiri I Ibiebele, Maria Celia Hughes, David C Whiteman, Penelope M Webb
Journal article | 2012 | British Journal of Nutrition
Epidemiological studies investigating the association between dietary intake and oesophageal cancer have mostly focused on nutrien..
Application of 10 percent formalin for the treatment of radiation-induced hemorrhagic proctitis.
Eric M Haas, H Randolph Bailey, I Faragher
Journal article | 2007 | Diseases of the Colon & Rectum
PURPOSE: Rectal instillation of 4 percent formalin solution has been described as a successful treatment for hemorrhagic radiation..
Rapid diagnostic test for hereditary nonpolyposis colon cancer kindred using polymerase chain reaction.
IG Faragher, RH Whitehead
Journal article | 1998 | Diseases of the Colon & Rectum
PURPOSE: We have identified a mutation in the hMLH1 gene from the proband of a hereditary nonpolyposis colorectal cancer kindred. ..
Honours, Awards and Fellowships
FCSSANZ - Fellow, Colorectal Surgical Society of Australia and New Zealand
FRACS - Fellow of the Royal Australasian College of Surgeons
FRCS - Fellow of the Royal College of Surgeons of England